Primary Researcher definition

Primary Researcher means the researcher engaged in the Project by the Primary Grant Holder or by the Institution, and identified as such (whether by name or role) in the Application. ‘Project’ the project detailed in the Application and for which the Funding is awarded. ‘Research’ any and all research to be carried out pursuant to the Project.
Sample 1Sample 2Sample 3
Primary Researcher means the researcher engaged in the Project by the Primary Grant Holder or by the Institution, and identified as such (whether by name or role) in the Application.
Sample 1Sample 2Sample 3

Examples of Primary Researcher in a sentence

  • Part 2 Standards of Information – Targets and Review A botanic garden collection is only as good as the information attached to the plants in it.

  • Regulations for Research StudentshipsA1.1 A Research Studentship is an award of Funding for Major Research Grants, Strategic Research Grants or Small Research Grants where the Primary Researcher is a Research Student.

  • In the element Primary Researcher, for instance, we distinguish between person and institution.

  • Access to the restricted data will be limited to the Primary Researcher identified in this Agreement.2. Copies of the restricted data or any data created on the basis of the original data will not be copied or made available to anyone other than those mentioned in this Data Access Agreement, unless formally authorized by the GNHR.3. The data will be processed only for the stated statistical and research purposes.

  • List individuals from affiliated institutions who are directly interacting or intervening with subjects:Name Department     The Primary Researcher along with individuals listed above are required to: Pass the CITI training required of IU Southeast Researchers found at https://www.citiprogram.org/Default.asp Instructions for accessing and completing the training are found on the Research Compliance webpage.

  • The identification will not be revealed to any person not included in the Data Access Agreement.5. The Primary Researcher will implement security measures to prevent unauthorized access to licensed microdata acquired from the GNHR.

  • Moreover, we decomposed two elements, Primary Researcher and Contributor, to increase the exactness.

  • The principal researcher must be an individual with authority to represent the receiving organization in agreements of this sort.2. ‘Receiving organization’ refers to the organization/university/establishment that employs the Primary Researcher.

  • Destruction of the microdata will be confirmed in writing to the GNHR by the Primary Researcher.

  • Wolfgang WeißDeutsche Universität für Verwaltungswissenschaften Speyer84 PUBLICATIONS 91 CITATIONS SEE PROFILE Some of the authors of this publication are also working on these related projects: EU Trade and Investment Partnership (EUTIP) - International Training Network View project Call for Papers: Legislative choice between Delegated and Implementing Rule-making View project All content following this page was uploaded by Wolfgang Weiß on 05 June 2020.

Related to Primary Researcher

  • Researcher means an individual who:

  • Basic research means any original investigation for the advancement of scientific or technological knowledge that will enhance the research capacity of this state in a way that increases the ability to attract to or develop companies, jobs, researchers, or students in this state.

  • Sponsored research means research, training, and other sponsored activities as defined by the federal Executive Office of the President, Office of Management and Budget:

  • Public research university means Rutgers, The State University

  • in vitro diagnostic medical device means any medical device which is a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, equipment, software or system, whether used alone or in combination, intended by the manufacturer to be used in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information:

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Collaborative lawyer means a lawyer who represents a party in a collaborative law process.

  • Principal Investigator means the Personnel who is identified as principally responsible for the performance and supervision of research associated with a Contract.

  • Collaborating physician means the physician who,

  • scientific research means any activity in the field of natural or applied science for the extension of knowledge;

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Collaboration has the meaning set forth in Section 2.1.

  • Research Use shall have the meaning given in Section 2.2.2 of this Agreement.

  • Collaboration Technology means all Collaboration Patents and Collaboration Know-How.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Clinical Trial means any human clinical trial of a Product.

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by the JDC and that otherwise fit the foregoing definition.

  • Pivotal Clinical Trial means a human clinical trial in any country that is prospectively designed to generate data intended to satisfy the requirements of 21 C.F.R. § 312.21(c) (as amended) in the U.S. or a similar clinical study prescribed by a Regulatory Authority from another country, from time to time, pursuant to Applicable Law.

  • Biological diversity means the variability among living organisms from all sources including, inter alia, terrestrial, marine and other aquatic ecosystems and the ecological complexes of which they are part; this includes diversity within species, between species and of ecosystems.

  • Phase III Clinical Trial means a human clinical trial of a product, the design of which is acknowledged by the FDA to be sufficient for such clinical trial to satisfy the requirements of 21 C.F.R. 312.21(c) (as amended or any replacement thereof), or a similar human clinical trial prescribed by the Regulatory Authority in a country other than the United States, the design of which is acknowledged by such Regulatory Authority to be sufficient for such clinical trial to satisfy the requirements of a pivotal efficacy and safety clinical trial.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Joint Research Committee or “JRC” has the meaning set forth in Section 3.1.1.

  • municipal spatial development framework means a municipal spatial development framework adopted by the Municipality in terms of Chapter 5 of the Municipal Systems Act;

  • Development Tool Kit means a DS Offering specifically designed for application or content development. A Development Tool Kit is either identified (i) with “CAA” or “ENOVIA Studio” in the DS Offering name, or (ii) in the Transaction Document and/or the Product Portfolio. Extended Enterprise User means an employee of Customer’s affiliate(s), supplier(s) and/or customer(s) authorized to use Customer’s DS Offering for the sole and exclusive purpose of enabling the Extended Enterprise User(s) to conduct business with Customer. The use of the DS Offering by any such Extended Enterprise User(s) 1) shall be solely limited to use (a) as configured and deployed by Customer and (b) in connection with the Extended Enterprise User’s performance of services for and on behalf of Customer, and 2) shall exclude any use by Extended Enterprise User (a) for its own account or a third party’s account, or (b) for the purpose of modifying, otherwise using, maintaining or hosting the DS Offering. Extended Enterprise Users are authorized if so specified in the Product Portfolio.